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Misclassiﬁcation and the use of register-
based indicators for depression
Introduction
During the last decade, interest in depression as a
major public health research issue has constantly
grown in the western world (1). Depression rating
scales are the preferred instruments to measure
depression in surveys, but their use is limited due to
selection bias with respect to non-respondents, lack
of statistical power and misclassiﬁcation. Some
recent studies have used population-based register
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Objective: To study the degree to which depression indicators based on
register data on hospital and antidepressant treatment suﬀer from
diﬀerential misclassiﬁcation with respect to gender, age and social
group.
Method: Data on 7378 persons were obtained by linking a cross-
sectional survey of Danish adults aged 40 and 50 years with
population-based registers. Misclassiﬁcation was analysed by
comparing survey data to register data on major depression using the
method proposed by Rothman and Greenland.
Results: Diﬀerential misclassiﬁcation was found. Adjustment for
misclassiﬁcation reduced womens odds ratios from 2.18 to 1.00 for
hospital treatment and from 1.70 to 1.10 for antidepressants. For the
lower social group, the corresponding odds ratios increased from 1.18
to 3.52, and from 1.35 to 2.32 respectively, whereas odds ratios with
respect to age remained almost unchanged.
Conclusion: Diﬀerential misclassiﬁcation should be considered when
register-based information about hospital and antidepressant
treatment are used as depression indicators.
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Significant outcomes
• As a result of differential misclassiﬁcation, gender differences in depression may be substantially
overestimated, and social inequality in depression may be substantially underestimated, if hospital
treatment and antidepressant treatment are used as indicators for depression.
• Differential misclassiﬁcation is less important with respect to age, when comparing age groups of 40
and 50 years.
Limitations
• The Major Depression Inventory, used as gold standard, may be misclassiﬁed itself compared to
clinical assessment. The extent and direction of this misclassiﬁcation can also be differential with
respect to the determinants investigated in this study.
• The results from the Major Depression Inventory are not independent from hospital and
antidepressant treatment.
• The results, especially for hospital treatment, are limited due to the small number of cases.
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information, such as hospitalizations with a diag-
nosis of depression or prescription of antidepres-
sants, as indicators for depression (2–8). These
indicators address the ﬁrst two limitations, but
they may introduce misclassiﬁcation. The misclas-
siﬁcation may be diﬀerential, as many cases remain
untreated and many of the treated cases are
selected according to major determinants.
In epidemiological studies on depression, disease
status has to be deﬁned and measured for every
person. The conventional clinical procedure is to
interview a person by a trained person and check
for the occurrence and duration of a predeﬁned set
of symptoms, which form the basis for the diag-
nosis according to the International Classiﬁcation
of Diseases (ICD) or Diagnostic and Statistic
Manual of Mental disorders (DSM) (9). For
epidemiological purposes, this procedure can be
used in small-scale studies, but it is often too costly
for larger samples. In surveys, one possibility is to
ask directly whether a person has had a depression
in the past or is currently diagnosed with depres-
sion. This information is viewed as an indicator of
the life-time prevalence of depression in the survey
population. It is more sophisticated to ﬁnd out
whether the individual has a clinical depression at
the time of the survey. The key is to ask about a set
of depressive symptoms that correspond to the
diagnostic schemes and algorithms used in the ICD
or DSM. Such rating scales have been used as case-
ﬁnding tools in clinical trials and epidemiological
studies (10, 11). The rising interest in depression
research and the mentioned limitations of the
rating scales have broadened the view on alterna-
tive ways to measure depression as an outcome.
In Denmark, administrative registers are avail-
able that cover the whole population and include
information about all in- and out-patient hospital
contacts as well as all dispensed drug prescriptions.
All Danish residents have the right to free medical
consultation from a general practitioner (GP),
medical consultation from specialists on referral
from a GP, free hospital treatment and subsidies
for prescribed drugs. Aside from this, residents can
directly consult private psychologists or psychia-
trists at their own expense. Through data linkage
with other registers or survey samples, it is possible
to use this register-based information on hospital
treatment for depression or on the prescription and
dispensation of antidepressants as outcome mea-
sures in large-scale longitudinal epidemiological
studies, with several measurement points during
the follow-up. However, there may be general
concerns about the validity of registers (12) as well
as special concerns about potential misclassiﬁca-
tion, which is the focus of this article.
Choosing measurements to deﬁne cases and non-
cases of depression, one pays particular attention
to low sensitivity, because this kind of misclassiﬁ-
cation means a loss of depression cases. There is
further interest in low speciﬁcity because this kind
of misclassiﬁcation increases the rate of false
positives among those assigned as being depressed.
Often, one tends to assume that, in terms of
sensitivity and speciﬁcity, the degree of misclassi-
ﬁcation in the outcome is similar or non-diﬀeren-
tial in all exposure groups, and the resulting odds
ratios (ORs) or risk ratios are then biased towards
the null. In the case of diﬀerential misclassiﬁcation,
however, where the sensitivity or speciﬁcity varies
across diﬀerent exposure levels, the results might
be seriously biased in either directions (13).
Aims of the study
The aim of this study is to illustrate the importance
of the issue by examining to what degree register
data on hospitalization, as a result of depression
and antidepressant treatment, are prone to diﬀer-
ential misclassiﬁcation with respect to gender, age
and social group. Comparing the occurrence of
depression measured by a rating scale in a survey
with the register data on depression treatment, the
sensitivity and speciﬁcity will be calculated for
gender, age and social groups. These results will be
used to adjust the crude associations between
determinants and hospital and antidepressant
treatment for diﬀerential misclassiﬁcation.
Material and methods
Study population and variables
Data were obtained by linking a cross-sectional
survey of Danish adults aged 40 and 50 years,
carried out by March 2000, with three population-
based administrative registers. The linkage proce-
dure makes use of the fact that each resident of
Denmark is assigned a unique central person
identiﬁcation number. For research purposes, Sta-
tistics Denmark is able to combine survey samples
with register information at the individual level
through an anonymous process, as done for this
study.
The following data sources have been used:
i) The survey sample is part of the Danish
Longitudinal Study on Work, Unemployment
and Health, which contains two representa-
tive samples of 40- and 50-year-old persons
and a supplemental sample of marginalized
persons, which was not included in this
study. Response rates were 68% and 69%
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respectively for the two-age samples (14). Data
on non-participants showed a higher propor-
tion of men, immigrants, and semiskilled or
unskilled workers as well as a higher propor-
tion of hospital treatment for depression and
antidepressant treatment. Depression was
measured with the Major Depression Inven-
tory (MDI). The inventory consists of 10
items that cover the DSM-IV diagnosis of
major depression. It assesses information on
depressive symptoms with a continuous dura-
tion of at least 2 weeks, which corresponds to
DSM-IV and ICD-10. The MDI has been
validated at clinical and population levels (10,
15, 16) with respect to the DSM-IV diagnosis.
Moreover, information on gender and age was
taken from the survey material.
ii) The Danish Psychiatric Central Register (17)
includes all persons in Denmark who have
been treated by the psychiatric hospital system
since 1970. From the register, we derived the
cases with the main diagnosis of depression at
admission, including bipolar aﬀective disorder
(ICD-10: F31, F32, F33 and F34), during the
time period between 1998 and 2002. Data on
all patients who had been treated as in- and
out-patients, but not single contacts with the
hospital ambulatory or emergency depart-
ment, were used. The admission prevalences
in 2000 and for the period from 1998 to 2002
were chosen as prevalence outcome measures.
Hospital admissions during the year 2000,
without registrations in the preceding 4 years,
were deﬁned as incident cases. For power
reasons, prevalence of permission from 1998–
2002 was used for the stratiﬁed analysis of
sensitivity and speciﬁcity.
iii) The Medicinal Product Statistics (18) contain
data on all prescribed medication, which has
been dispensed at pharmacies in Denmark
since 1995. There is no other legal way in
Denmark to obtain prescribed medication
(except from hospitals in connection with
admission). The registrations are coded
according to the Anatomical Therapeutic
Chemical (ATC) classiﬁcation system (19).
Registrations for all antidepressants (ATC:
N06A), were used. In addition to the ATC
codes, information about the date of prescrip-
tion and the deﬁned daily dose (DDD) was
taken. Prevalence variables as indicators for
antidepressant treatment were deﬁned for the
year 2000 and for the period from 1998 to
2002. In the same way as for the hospital
admissions, a measure for the incidence in
2000 was deﬁned. Finally, in order to gain
enough power for the analysis of sensitivity
and speciﬁcity, we used a measure for the
3-year cumulative incidence (from 2000 to
2002). With respect to the cumulative amount
of DDD, we used two measures: a) the
dispensing of at least one DDD of any
antidepressant, and b) more than 179 DDD
of any combination of diﬀerent antidepres-
sants, which indicates a continuous treatment,
for at least 6 months.
iv) Because of the high non-response rate with
respect to questions about social position in
the survey material, administrative register
information from Statistics Denmark at the
level of education obtained before the year
2000 as the indicator for social position was
taken. To increase the power of the analysis,
we dichotomized it into two social groups:
low and middle ⁄high where low means no
education beyond lower secondary school.
As a result of the data-linkage procedure, we
were able to analyse a sample of 7378 persons who
participated in the survey and had information on
all variables used in the analysis.
Statistical analysis
In the initial analysis, the prevalence and incidence
of depression, hospital treatment for depression
and antidepressant treatment for the sample of 40-
and 50-year-old persons was calculated. The crude
ORs for prevalent hospital treatment and prevalent
and incident antidepressant treatment with respect
to gender, age and social group were also calcu-
lated.
It is a central assumption in this analysis that the
MDI measure of depression provides the most
reliable information about a persons state of
depression. We used the algorithm for Major
Depression only, which follows the DSM-IV rules
to classify persons as depression cases, because
there were not enough cases to work with diﬀerent
levels of depressiveness from the ICD-10. As
measures of the degree of accordance between
MDI and hospital treatment, and MDI and
prescription and delivery of antidepressants, the
sensitivity (percentage of persons indexed as major
depression cases who had hospital or antidepres-
sant treatment respectively) and the speciﬁcity
(percentage of persons indexed as non-cases of
major depression who have no hospital or antide-
pressant treatment respectively) were calculated for
every stratum of gender, age and social group.
Sensitivity and speciﬁcity can be similar or diﬀerent
across the strata, which was assumed to be a sign
Thielen et al.
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of non-diﬀerential or diﬀerential misclassiﬁcation
respectively. In the ﬁnal analysis, the former
calculated crude ORs for misclassiﬁcation was
adjusted with respect to the results for sensitivity
and speciﬁcity in the diﬀerent strata. In this
exemplary analysis, the outcome measure was
adjusted using a method based on sensitivity (Se),
speciﬁcity (Sp) and false positive (Fp), which has
been described by Rothman and Greenland (20).
The following formulae were used:
A ¼ ðA
  FpnÞ
ðSeþ Sp 1Þ and B ¼ n A;
where A and B represent the estimated true
numbers of diseased and non-diseased subjects
respectively and A* the number of subjects classi-
ﬁed as diseased by the measure under study. These
equations are used for every stratum respectively.
New adjusted estimates can then be calculated
from these corrected counts, which have been
done for the ORs in this study.
Results
Table 1 shows the descriptive results from the
study. For the year 2000, the estimated point
prevalence for Major Depression in the age
groups of 40 and 50 years was about 2.7%.
During the year 2000, about 5% of the population
received some kind of antidepressant treatment at
least one time. More than every second person of
this former group and 2.8% of the population
sample received at least 180 DDD, which is
equivalent to 6 months medical treatment. About
1.2% of the population started antidepressant
treatment during the year 2000, after at least
4 years without treatment. Among those, 28%
received at least 180 DDD.
The point prevalence for depression according to
hospital treatment was 0.2% during the year 2000
and 0.8% during the 5-year period between 1998
and 2002.
As shown in Table 2, compared to men, women
had up to twice as high OR for hospital and
antidepressant treatment, while the OR with regard
to the MDI was similar in men and women. Due to
a lack of power, we calculated the OR for the 3-year
cumulative incidence (2000–2002) only for pre-
scribed antidepressants. The OR was again higher
for women than for men, but less pronounced than
ORs for the prevalence, indicating a longer dura-
tion of antidepressant treatment for women.
The older age group had higher odds for hospital
treatment (not signiﬁcant) and antidepressant
treatment, independent of the time frame. As was
seen for gender, the OR for the cumulative
incidence of antidepressant use was at a lower
level than for prevalence, but not signiﬁcant.
Table 1. Indicators of depression and their prevalence and incidence in a sample
of the Danish population, percentages and absolute numbers for 2000, 1998–2002













In- and out-patients 0.18 (13) 0.83 (63) 0.11 (8)









2.81 (207) 6.09 (449) 0.33 (24)
DDD, defined daily dose.
*No registrations in the preceding 4 years.
Hospital register, diagnose F31–F34 (ICD-10).
Medicinal Product Statistics.
Table 2. Odds ratios and 95% confidence intervals for the indicators of prevalent
depression in 2000 and 1998–2002, and the cumulative incidence between 2000















1.01 (0.76–1.35) – –




1.78 (1.43–2.21) 1.70 (1.46–2.00) 1.45 (1.14–1.84)
Antidepressants,
P
DDD > 6 months





1.12 (0.84–1.48) – –




1.47 (1.19–1.81) 1.35 (1.16–1.57) 1.13 (0.90–1.43)
Antidepressants,
P
DDD > 6 months





2.34 (1.75–3.12) – –




1.40 (1.11–1.77) 1.35 (1.14–1.60) 1.10 (0.84–1.43)
Antidepressants,
P
DDD > 6 months
1.35 (1.00–1.83) 1.30 (1.05–1.60) 1.02 (0.61–1.72)
OR, Odds ratio; 95% CI, 95% confidence interval; DDD, defined daily dose.
*No registrations in the preceding 4 years.
Hospital register, diagnose F31–F34 (ICD-10).
Medicinal Product Statistics.
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For the point and period prevalence, we found
that the lower social group has a 30–40% higher
odds for antidepressant treatment; for the inci-
dence that no signiﬁcant diﬀerence was found
between the social groups. The OR for MDI as the
outcome was 2.34 in the lower social group, which
was more than twice as high odds as the mid-
dle ⁄high social group.
Table 3 shows the sensitivity and speciﬁcity for
the register data on hospital and antidepressant
treatment by gender, age and social group. Hospi-
tal treatment as an indicator showed a sensitivity
below 10%, which means that 90% of the persons
categorized as depressive by the MDI in 2000 did
not have any hospital treatment between 1998 and
2002. On the other hand, hospital treatment
showed the highest speciﬁcity for all groups,
around 99.5%. Thus, only about 0.5% among
those not treated by the psychiatric hospital system
between 1998 and 2002 has been identiﬁed by the
MDI as a depression case.
When comparing men and women, we found
large, but non-signiﬁcant, diﬀerences in sensitivity
for hospital and antidepressant treatment in 2000,
during 1998–2002 and for the 3-year cumulative
incidence. The speciﬁcity for antidepressant treat-
ment in 2000 and during 1998–2002, however, was
signiﬁcantly diﬀerent, which indicates diﬀerential
misclassiﬁcation with respect to gender. The dif-
ferences between the two-age groups for the
sensitivity were prominent, but non-signiﬁcant for
the prevalence of hospital treatment and the
incidence of antidepressant treatment. For the
prevalence of antidepressant treatment, we found
signiﬁcantly higher speciﬁcity for the younger age
group indicating diﬀerential misclassiﬁcation with
respect to age.
For the social groups, there were marked, but
non-signiﬁcant, diﬀerences in sensitivity for all
measures, but only small and insigniﬁcant diﬀer-
ences in speciﬁcity between the indicators of
depression. From this, we cannot exclude diﬀeren-
tial misclassiﬁcation with respect to social group.
Finally, we adjusted the ORs for hospital and
antidepressant treatment by using the calculated
estimates for sensitivity and speciﬁcity (Table 4).
While the crude prevalence odds for women were
Table 3. Comparison of cases of major depression measured with the MDI in 2000 and depression indicators from the registers
Se Sp Se Sp
Gender Male Female
In- and out-patients, 1998–2002* 4.3 (1.2–10.7) 99.6 (99.3–99.8) 11.5 (6.1–19.3) 99.2 (98.3–99.4)
Antidepressants, 2000 30.1 (21.0–40.5) 97.1 (96.5–97.6) 33.7 (24.7–43.6) 94.5 (93.7–95.2)
Antidepressants, 1998–2002 44.1 (33.8–54.8) 93.4 (92.6–94.3) 54.8 (44.7–64.6) 89.0 (87.9–89.9)
Antidepressants, Inc., 2000–2002 10.8 (5.3–18.9) 96.9 (96.3–97.5) 16.4 (9.8–24.9) 95.6 (94.9–96.3)
Age 40 years 50 years
In- and out-patients, 1998–2002* 9.7 (4.5–17.6) 99.5 (99.2–99.7) 6.7 (2.8–13.4) 99.3 (98.9–99.5)
Antidepressants. 2000 33.3 (23.9–43.9) 96.7 (96.0–97.2) 30.8 (22.1–40.6) 94.7 (94.0–95.4)
Antidepressants, 1998–2002 50.5 (40.0–61.1) 92.4 (91.5–93.3) 49.0 (39.1–59.0) 89.8 (88.7–90.7)
Antidepressants, Inc. 2000–2002 11.8 (6.1–20.2) 96.4 (95.8–97.0) 15.4 (9.1–23.8) 96.1 (95.4–96.7)
Social group Low Middle ⁄ high
In- and out-patients, 1998–2002* 9.5 (4.2–17.9) 99.5 (99.0–99.8) 7.1 (3.1–13.5) 99.3 (99.1–99.5)
Antidepressants, 2000 36.9 (26.6–48.1) 95.1 (94.0–96.1) 28.3 (20.2–37.6) 95.9 (95.3–96.4)
Antidepressants, 1998–2002 46.4 (35.5–57.7) 89.5 (88.0–90.9) 52.2 (42.6–61.7) 91.6 (90.8–92.3)
Antidepressants, Inc., 2000–2002 9.5 (4.2–17.9) 96.0 (94.9–96.8) 16.8 (10.4–25.0) 96.4 (95.8–96.8)
Se, sensitivity; Sp, specificity; DDD, defined daily dose.
*Hospital register, diagnoses F31–F34 (ICD-10).
Medicinal Product Statistics, antidepressants
P
DDD > 0.
Medicinal Product Statistics, antidepressants
P
DDD > 0, cumulative incidence, no registrations in the preceding 4 years.
Table 4. Odds ratio for the indicators of depression in 2000, 1998–2002 and the
cumulative incidence between 2000 and 2002 by gender, age and social group,





















In- and out-patients* – – 2.18 1.00 – –
Antidepressants 1.78 1.03 1.70 1.10 1.45 1.37
Age (50 years)
In- and out-patients* – – 1.26 1.50 – –
Antidepressants 1.47 1.01 1.35 1.20 1.13 1.14
Social group (low)
In- and out-patients* – – 1.18 3.52 – –
Antidepressants 1.40 2.28 1.35 2.32 1.10 2.27
OR, Odds ratio; DDD, defined daily dose.
*Hospital register, diagnoses F31–F34 (ICD-10).





up to twice as large as the odds for men, the
adjusted ORs came close to 1. On the contrary, the
gender OR for the incidence of prescription and
delivery of antidepressant treatment remained
almost unchanged. The age diﬀerence, with
higher odds for the older age group for antide-
pressant treatment, disappeared for the point
prevalence in 2000, but not for the period preva-
lence from 1998–2002. The age OR for incidence of
antidepressant prescription remained almost
unchanged, but the OR for prevalence of hospital
treatment increased. The largest changes were
observed for the social groups where all ORs
increased substantially after adjustment.
Discussion
The study demonstrated a considerable degree of
diﬀerential misclassiﬁcation when we used the
prevalence of hospital treatment or the preva-
lence and incidence of antidepressant treatment
as outcome indicators for depression compared
with the major depression rating scale. Adjust-
ment of the crude eﬀect estimates in the analyses
showed that one would strongly overestimate the
gender eﬀect on depression (positive bias in the
odds for females compared to males) and under-
estimate the eﬀect of social group on depression
(negative bias in the OR of low social group
compared to the middle ⁄high group), when the
prevalence of hospital or antidepressant treat-
ment were used as indicators. The use of incident
antidepressant treatment as an indicator gave a
fairly unbiased OR estimate for gender. The
eﬀect of social group, however, is negatively
biased. A consistent pattern in the results of the
adjustment, which would favour one of the tested
indicators in general, was not found.
The higher risk of antidepressant treatment for
the lower social group conﬁrms another Danish
study (21), but diﬀers from a Finish study, which
ﬁnds antidepressant treatment less common among
low educational groups (3). Diﬀerential and non-
diﬀerential misclassiﬁcation of the measure of
outcome, but also of the exposure, is a well-studied
source of bias (22–24). Non-diﬀerential misclassi-
ﬁcation in epidemiological studies can be dealt with
because we know it changes the eﬀect estimate
towards null, which results in an underestimation
of the true association. Several correction methods
are available (25, 26). Diﬀerential misclassiﬁcation,
however, gives rise to more concern, because bias
may go in either direction, as illustrated in the
present study. This should be accounted for when
register information is used, even when data
quality is high, as in the Danish case with a
population coverage of about 100% and good
diagnostic validity for the hospital-treated cases
(27). Another important issue is that epidemiolog-
ical studies have to deal with misclassiﬁcation not
only for the outcome, but also for the exposure as
well as for all possible confounders. When several
misclassiﬁcation problems have to be dealt with at
the same time, there is a need for more advanced
correction methods (25, 26). These potential addi-
tional sources of bias might aﬀect the risk estimate
substantially in both directions.
The low sensitivity for hospital treatment, also
within a 5-year time period, reﬂects that only a very
small part of the persons who participated in the
survey and classiﬁed as depressed by the MDI
received treatment in the hospital system. This
problem is even ampliﬁed by selection bias. In
general as in this population study, more severe
cases do not participate in surveys, and at the same
time are more likely to be found in hospital
registers. Because non-response rates are diﬀerent
for gender, age and social groups, this could also
diﬀerentially aﬀect the rates and ratios, but
because we expect the MDI to measure with
similar precision among non-participants, it
would not aﬀect the adjustment.
Healthcare utilization bias is also relevant with
regard to antidepressant treatment; not every-
body with a depression is getting antidepressants,
because there are other treatment options,
patients do not want them or there is no contact
with the healthcare system. Again this can aﬀect
the exposures diﬀerently. For example, may
higher social groups have more frequently
access to and use psychotherapy compared to
lower social groups, which would result in
diﬀerential misclassiﬁcation. Also, there are
other medical indications besides depression for
which antidepressants are a treatment choice.
Anxiety, pain and sleep disturbances are the most
frequent (28, 29). This might increase the number
of false-positive cases in the analysis, which in
turn aﬀects the speciﬁcity. Gender, age or social
group diﬀerences in prevalence of those indica-
tions for antidepressant treatment might again
result in diﬀerential misclassiﬁcation. Moreover,
missing true cases and false-positive cases may
result from measurement error with respect to the
MDI. A population-based validation study (10)
ﬁnds misclassiﬁcation of the MDI measure,
expressed in sensitivity (67%) and speciﬁcity
(81%); unfortunately, we do not know the
corresponding values for this study sample. If
we rely on these validation results, we could
hardly use the major depression prevalence mea-
sured by MDI in absolute terms. As we use only
Misclassiﬁcation and the use of register-based indicators for depression
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relative measures and an adjustment method that
is independent of the prevalence, however, we
think it is acceptable for this exemplifying anal-
ysis. On the other hand, we cannot rule out
diﬀerential misclassiﬁcation with respect to
gender, age or social group for the measurement
of the MDI, which is a potential bias to the
study results.
Major Depression Inventory deﬁnes persons as
cases of major depression if they have been
depressed according to the DSM-IV algorithm
for at least 2 weeks preceding the survey. This
point prevalence can, by deﬁnition, only capture
a certain amount of all persons who had a major
depression at least once in 2000 or between 1998
and 2002. Repeated measurement of the MDI
would provide a better estimate of the 1-year
prevalence for major depression, as it improves
the chances of ﬁnding cases of depression at
other times of the year and which accordingly
would be indexed in this analysis as false
positives. Assuming that all exposure groups
had similar degrees of misclassiﬁcation at other
measurement points during the year, we do not
expect this to cause bias in the adjustment. More
measurement points, however, would improve
precision. Generally, this point prevalence mea-
surement issue results in a more conservative
estimate of the speciﬁcity.
Yet another important issue relates to the fact
that we use treatment measures for depression,
which have a potential eﬀect on the state of
depression and on the MDI score respectively. If
the treatment takes place around the time of the
survey, one would expect successfully treated
persons not to be indexed as major depression
cases. This again would result in a lower spec-
iﬁcity. If treatment response on MDI is diﬀeren-
tial in relation to gender, age and social group,
this would aﬀect the results, but we cannot
account for this in this study. Finally, one has to
keep in mind that gender, age and social position
are often included as covariates in epidemiolog-
ical studies. Diﬀerential misclassiﬁcation may
also in these situations aﬀect the results when
depression indicators are the outcome.
Acknowledgements
The study was supported by grants of the Danish Work
Environment Fund (grant numbers: 24-2005-09 and 2-2006-
04), and of the Ministry of Health and Prevention, Public
Health Fund (grant number: 2005-14033-8). The funding
agencies were not involved in any stage of the study, including
data collection and analysis, manuscript writing and decision
to submit the manuscript for publication. All researchers are




1. Prince M, Patel V, Saxena S et al. No health without
mental health. Lancet 2007;8:370.
2. Dalton SO, Mellemkjaer L, Olsen JH, Mortensen PB,
Johansen C. Depression and cancer risk: a register-based
study of patients hospitalized with aﬀective disorders,
Denmark, 1969–1993. Am J Epidemiol 2002;155:1088–
1095.
3. Kivimaki M, Gunnell D, Lawlor DA et al. Social inequalities
in antidepressant treatment and mortality: a longitudinal
register study. Psychol Med 2007;37:373–382.
4. Lawlor DA, Hart CL, Hole DJ, Gunnell D, Davey SG. Body
mass index in middle life and future risk of hospital
admission for psychoses or depression: ﬁndings from the
Renfrew ⁄Paisley study. Psychol Med 2007;37:1151–1161.
5. Virtanen M, Honkonen T, Kivimaki M et al. Work stress,
mental health and antidepressant medication ﬁndings
from the Health 2000 Study. J Affect Disord 2007;98:189–
197.
6. Virtanen M, Kivimaki M, Ferrie JE et al. Temporary
employment and antidepressant medication: a register
linkage study. J Psychiatr Res 2008;42:221–229.
7. Wieclaw J, Agerbo E, Mortensen PB, Bonde JP. Occupa-
tional risk of aﬀective and stress-related disorders in the
Danish workforce. Scand J Work Environ Health 2005;
31:343–351.
8. Wieclaw J, Agerbo E, Mortensen PB, Burr H, Tuchsen F,
Bonde JP. Work related violence and threats and the risk of
depression and stress disorders. J Epidemiol Community
Health 2006;60:771–775.
9. Jablensky A. The nature of psychiatric classiﬁcation: issues
beyond ICD-10 and DSM-IV. Aust NZ J Psychiatry
1999;33:137–144.
10. Forsell Y. The Major Depression Inventory versus
Schedules for Clinical Assessment in Neuropsychiatry in a
population sample. Soc Psychiatry Psychiatr Epidemiol
2005;40:209–213.
11. Olsen LR, Mortensen EL, Bech P. Prevalence of major
depression and stress indicators in the Danish general
population. Acta Psychiatr Scand 2004;109:96–103.
12. Byrne N, Regan C, Howard L. Administrative registers in
psychiatric research: a systematic review of validity studies.
Acta Psychiatr Scand 2005;112:409–414.
13. Greenland S. Basic methods for sensitivity analysis of
biases. Int J Epidemiol 1996;25:1107–1116.
14. Christensen U, Lund R, Damsgaard MT et al. Cynical hos-
tility, socioeconomic position, health behaviors, and
symptom load: a cross-sectional analysis in a Danish
population-based study. PsychosomMed 2004;66:572–577.
15. Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard
W. The sensitivity and speciﬁcity of the Major Depression
Inventory, using the Present State Examination as the in-
dex of diagnostic validity. J Affect Disord 2001;66:159–
164.
16. Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P. The
internal and external validity of the Major Depression
Inventory in measuring severity of depressive states. Psy-
chol Med 2003;33:351–356.
17. Munk-Jorgensen P, Kastrup M, Mortensen PB. The Danish
psychiatric register as a tool in epidemiology. Acta Psy-
chiatr Scand Suppl 1993;370:27–32.
Thielen et al.
318
18. Danish Medicines Agency (Laegemiddelstyrelsen). Danish
products statistics. Available at: http://www.laegemiddel-
styrelsen.dk (cited 10 January 2008).
19. WHO Collaborating Centre for Drug Statistics Method-
ology. Guidelines for ATC classiﬁcation and DDD
assignment. Oslo: WHO Collaborating Centre for Drug
Statistics, 2004.
20. Rothmann K, Greenland S. Modern epidemiology, 3rd edn.
Philadelphia, PA: Lippincott-Raven, 2006.
21. Hansen DG, Sondergaard J, Vach W et al. Socio-economic
inequalities in ﬁrst-time use of antidepressants: a popula-
tion-based study. Eur J Clin Pharmacol 2004;60:51–55.
22. Copeland KT, Checkoway H, McMichael AJ, Holbrook RH.
Bias due to misclassiﬁcation in the estimation of relative
risk. Am J Epidemiol 1977;105:488–495.
23. Hofler M. The eﬀect of misclassiﬁcation on the estimation
of association: a review. Int J Methods Psychiatr Res
2005;14:92–101.
24. Walter SD, Irwig LM. Estimation of test error rates, dis-
ease prevalence and relative risk from misclassiﬁed data: a
review. J Clin Epidemiol 1988;41:923–937.
25. Bashir SA, Duffy SW. The correction of risk estimates for
measurement error. Ann Epidemiol 1997;7:154–164.
26. Gustafson P. Measurement error and misclassiﬁcation in
statistics and epidemiology, 1st edn. Boca Raton: Chap-
man & Hall ⁄CRC, 2004.
27. Kessing LV. Validity of diagnoses and other clinical register
data in patients with aﬀective disorder. Eur Psychiatry
1998;13:392–398.
28. Angst J. Psychiatric diagnoses: the weak component of
modern research. World Psychiatry 2007;6:30–31.
29. Trifiro G, Barbui C, Spina E et al. Antidepressant drugs:
prevalence, incidence and indication of use in general
practice of Southern Italy during the years 2003–2004.
Pharmacoepidemiol Drug Saf 2007;16:552–559.
Misclassiﬁcation and the use of register-based indicators for depression
319
